Global Idiopathic Pulmonary Fibrosis Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Idiopathic Pulmonary Fibrosis Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Idiopathic Pulmonary Fibrosis
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Idiopathic Pulmonary Fibrosis Market by Type

• 3.1 By Type
  • 3.1.1 Systemic corticosteroids
  • 3.1.2 Immunosuppressant drugs
  • 3.1.3 Tyrosine kinase inhibitors
  • 3.1.4 Antifibrotic agents
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Idiopathic Pulmonary Fibrosis Baxter (Company Profile, Sales Data etc.)

• 4.2 Boehringer Ingelheim (Company Profile, Sales Data etc.)
• 4.3 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
• 4.4 Prometheus Laboratories (Company Profile, Sales Data etc.)
• 4.5 Afferent Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.6 Amgen (Company Profile, Sales Data etc.)
• 4.7 Biogen (Company Profile, Sales Data etc.)
• 4.8 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
• 4.9 Cipla (Company Profile, Sales Data etc.)
• 4.10 FibroGen (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospital
  • 6.1.2 Demand in Clinic
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Idiopathic Pulmonary Fibrosis

Table Application Segment of Idiopathic Pulmonary Fibrosis

Table Global Idiopathic Pulmonary Fibrosis Market 2013-2024, by Application, in USD Million

Table Major Company List of Systemic corticosteroids

Table Major Company List of Immunosuppressant drugs

Table Major Company List of Tyrosine kinase inhibitors

Table Major Company List of Antifibrotic agents

Table Global Idiopathic Pulmonary Fibrosis Market 2013-2018, by Type, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Market 2013-2018, by Type, in Volume

Table Global Idiopathic Pulmonary Fibrosis Market Forecast 2019-2024, by Type, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Market Forecast 2019-2024, by Type, in Volume

Table Baxter Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Prometheus Laboratories Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Prometheus Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Afferent Pharmaceuticals Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Afferent Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table FibroGen Overview List

Table Idiopathic Pulmonary Fibrosis Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Idiopathic Pulmonary Fibrosis Sales Revenue 2013-2018, by Company, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Sales Revenue Share, by Company, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Sales Volume 2013-2018, by Company, in Volume

Table Global Idiopathic Pulmonary Fibrosis Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Idiopathic Pulmonary Fibrosis Demand Forecast 2019-2024, by Application, in USD Million

Table Idiopathic Pulmonary Fibrosis Demand Forecast 2019-2024, by Application, in Volume

Table Idiopathic Pulmonary Fibrosis Production 2013-2018, by Region, in USD Million

Table Idiopathic Pulmonary Fibrosis Production 2013-2018, by Region, in Volume

Table Global Idiopathic Pulmonary Fibrosis Market 2013-2018, by Region, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Market Share 2013-2018, by Region, in USD Million

Table Global Idiopathic Pulmonary Fibrosis Market 2013-2018, by Region, in Volume

Table Global Idiopathic Pulmonary Fibrosis Market Share 2013-2018, by Region, in Volume

Table North America Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in USD Million

Table North America Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in Volume

Table Europe Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in USD Million

Table Europe Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in Volume

Table South America Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in USD Million

Table South America Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size 2013-2018, by Country, in Volume

Table Idiopathic Pulmonary Fibrosis Market Forecast 2019-2024, by Region, in USD Million

Table Idiopathic Pulmonary Fibrosis Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Idiopathic Pulmonary Fibrosis Market Growth 2013-2018, by Type, in USD Million

Figure Global Idiopathic Pulmonary Fibrosis Market Growth 2013-2018, by Type, in Volume

Figure North America Idiopathic Pulmonary Fibrosis Market Concentration, in 2018

Figure Europe Idiopathic Pulmonary Fibrosis Market Market Concentration, in 2018

Figure Asia-Pacific Idiopathic Pulmonary Fibrosis MMarket Concentration, in 2018

Figure South America Idiopathic Pulmonary Fibrosis Market Concentration, in 2018

Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Concentration, in 2018

Figure Idiopathic Pulmonary Fibrosis Demand in Hospital, 2013-2018, in USD Million

Figure Idiopathic Pulmonary Fibrosis Demand in Hospital, 2013-2018, in Volume

Figure Idiopathic Pulmonary Fibrosis Demand in Clinic, 2013-2018, in USD Million

Figure Idiopathic Pulmonary Fibrosis Demand in Clinic, 2013-2018, in Volume

Figure Idiopathic Pulmonary Fibrosis Demand in Others, 2013-2018, in USD Million

Figure Idiopathic Pulmonary Fibrosis Demand in Others, 2013-2018, in Volume

Figure North America Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in USD Million

Figure North America Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in Volume

Figure Europe Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in USD Million

Figure Europe Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in Volume

Figure South America Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in USD Million

Figure South America Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview